Top Markets
#1 Bedrock Bedrock +51.79%
#2 pippin pippin +19.58%
#3 IQ IQ +19.18%
#4 Naoris Protocol Naoris Protocol +18.03%
#5 Irys Irys +17.31%
#6 ETHGas ETHGas +16.17%
#7 Aria.AI Aria.AI +14.78%
#8 Buttcoin Buttcoin +14.36%
#9 Magma Finance Magma Finance +14.06%
#10 DUSK Network DUSK Network +11.60%
Coin of the day
Bedrock Bedrock
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classifica tra le azioni #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Prezzo delle azioni
$0.16328419
Capitalizzazione di mercato
$204.14K
Variazione (1 giorno)
4.35%
Variazione (1 anno)
102.45%
Paese
GB
Scambia Fusion Antibodies plc (FAB)

Categoria

Healthcare
Storico del prezzo dell'azione per Fusion Antibodies plc (FAB)
Prezzo di chiusura più alto: $0.17 il 2026-03-01

Prezzo di chiusura più basso: $2.40 il 2017-12-01
Storico del prezzo dell'azione di Fusion Antibodies plc dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -21.78%
2025 153.61%
2024 38.42%
2023 -88.93%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $36.82 -51.12%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $451.24 -11.82%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $736.53 11.43%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $294.88 52.33%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $681.85 12.16%
NL